Skip to content

Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy

Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy; the FANCY Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03510923
Acronym
FANCY
Enrollment
17380
Registered
2018-04-27
Start date
2018-05-01
Completion date
2020-12-24
Last updated
2024-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appendectomy, Appendiceal Neoplasms, Appendix, Cholecystectomy, Gallbladder, Gallbladder Neoplasms

Keywords

Appendix, Appendectomy, Gallbladder, Cholecystectomy, Neoplasms, Pathology, Selective, Routine

Brief summary

The FANCY study will investigate whether a selective policy of histopathological examination of appendices and gallbladders based on the intraoperative findings of the surgeon is safe and cost-effective.

Detailed description

Traditionally, all surgically removed appendices and gallbladders are sent to the department of pathology for histopathological examination. This is most likely not necessary in appendices and gallbladders that are not suspicious for a tumour when inspected visually or by palpation. If not detected by visual inspection or palpation, the tumour is usually of early stage and already treated with the resection of the organ. A policy of selective histopathological examination based on the intraoperative findings of the surgeon can probably reduce the amount of appendices and gallbladders that have to be examined by the pathologist, without a risk of undertreatment, with less risk of overtreatment and huge savings annually. In the FANCY study, a nationwide prospective multicenter observational cohort study, all appendices and gallbladders will be evaluated for tumours by visual inspection and palpation by the operating surgeon. The operating surgeon will report his or her findings and also write down whether he or she thinks there is an indication for histopathological examination. Subsequently, all specimens are sent to the pathologist for histopathological examination. Therefore, no aberrant findings will be missed due to this study. The prospective cohort can be compared through modelling to a hypothetical situation where appendices and gallbladders are only examined by the pathologist on indication. The primary outcome is the number of patients per 1000 examined appendices/gallbladders with a neoplasm requiring additional therapy benefitting the patient that would have been unnoticed in the policy of selective histopathological examination.

Interventions

OTHERInspection and palpation of the appendix

The removed appendix will be evaluated for tumours by the operating surgeon by visual inspection and digital palpation of the specimen. The appendix will not be opened. The surgeon will report his or her findings on a predefined scoring form: he or she will report all abnormalities and writes down whether he or she considers there is an indication for histopathological examination. Subsequently, all specimens will be sent for histopathological examination. Histopathological examination will be conducted according to the local protocol. In case of a neoplasm of the appendix, the treatment strategy is discussed and decided by the local multidisciplinary team. If an additional more extensive resection is decided to be appropriate, the specimens of the re-resection will be evaluated for the presence of remaining tumour tissue.

OTHERInspection and palpation of the gallbladder

The removed gallbladder will be evaluated for tumours by the operating surgeon by visual inspection and digital palpation of the specimen. The gallbladder is opened in its length, without cutting the cystic duct, and is inspected and palpated. The surgeon will report his or her findings on a predefined scoring form: he or she will report all abnormalities and writes down whether he or she considers there is an indication for histopathological examination. Subsequently, all specimens will be sent for histopathological examination. Histopathological examination will be conducted according to the local protocol. In case of a neoplasm of the gallbladder, the treatment strategy is discussed and decided by the local multidisciplinary team. If an additional more extensive resection is decided to be appropriate, the specimens of the re-resection will be evaluated for the presence of remaining tumour tissue.

Sponsors

ZonMw: The Netherlands Organisation for Health Research and Development
CollaboratorOTHER
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients scheduled to undergo an appendectomy or cholecystectomy in the elective or non-elective setting.

Exclusion criteria

* Primary indication for surgery: strong suspicion or proven malignancy in the appendix or gallbladder. * Appendix or gallbladder removed as part of more extensive surgery, so-called incidental appendectomies or cholecystectomies. * Patients included in the ACCURE trial (effect of appendectomy on ulcerative colitis). * The presence of a gallbladder polyp of \>10 mm on preoperative imaging.

Design outcomes

Primary

MeasureTime frameDescription
Unnoticed neoplasms requiring additional therapy benefitting the patient3 monthsNumber of patients per 1000 examined appendices/gallbladders with a neoplasm requiring additional therapy benefitting the patient that would have been unnoticed in the policy of selective histopathological examination.
Costs3 monthsCosts of the policy with selective and with routine histopathological examination of the appendix/gallbladder.

Secondary

MeasureTime frameDescription
Malignancies requiring more extensive resection or other additional treatment3 monthsIncidence of malignancies in resected appendices and gallbladders that subsequently require more extensive resection or other additional treatment.
Benefit of additional resection2 weeksRemaining tumour tissue and/or positive lymph nodes in re-resection specimen
Malignancies2 weeksIncidence of malignancies in resected appendices and gallbladders
Other aberrant findings2 weeksIncidence of other aberrant findings as parasite infections, endometriosis, granulomatosis and benign neoplasms.
Other aberrant findings requiring additional therapy3 monthsIncidence of other aberrant findings as parasite infections, endometriosis, granulomatosis and benign neoplasms that require additional therapy.
Harm of additional resection1 monthIncidence of postoperative complications
Unnoticed malignancies2 weeksIncidence of unnoticed malignancies in resected appendices and gallbladders

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026